Dersimelagon, an effective oral treatment for patients with erythropoietic protoporphyria: Phase 2 trial Medha Baranwal8 July 2023 9:45 AM ISTUSA: A phase 2 study published in The New England Journal of Medicine claimed that oral dersimelagon may be a safe and effective treatment option for...
Vorasidenib shows promising results in IDH1- or IDH2-Mutant low-grade gliomas: NEJM Dr.Niharika Harsha B7 July 2023 8:00 PM ISTNew research revealed that Vorasidenib, an oral brain-penetrant inhibitor of mutant IDH1 and IDH2 enzymes significantly improves progression-free...
Pegozafermin, a potential treatment for improving fibrosis in NASH patients: Phase 2b Trial Dr. Kamal Kant Kohli5 July 2023 8:00 PM ISTUSA: The positive outcomes of a phase 2b trial support the further advancement of pegozafermin into phase 3 trials for NASH treatment. If successful,...
Use of high-dose hemodiafiltration improves survival in individuals with kidney failure: NEJM Chumbeni4 July 2023 10:30 AM ISTNetherlands: Researchers have found in the multinational, randomized, controlled trial involving 1360 kidney failure patients that high-dose...
Transcatheter repair safe and effective among patients with mitral regurgitation secondary to cardiomyopathy: NEJM Aditi3 July 2023 11:00 AM ISTPatients receiving transcatheter repair of mitral regurgitation secondary to cardiomyopathy have good safety outcomes compared to medical therapy...
Nivolumab plus chemotherapy improves survival in Stage III Non-Small-Cell Lung Cancer: NEJM Chumbeni30 Jun 2023 8:00 PM ISTSpain: A recent study published in The New England Journal of Medicine has revealed that combining Nivolumab and Chemotherapy treatment in patients...
Dolutegravir based ART superior to standard care in treating Children with HIV-1 Infection Chumbeni29 Jun 2023 8:00 PM ISTDr Anna Turkova and the team has found in a new study that dolutegravir-based ART for children and adolescents with HIV-1 infection has unveiled a...
Investigational drug Retatrutide tied to major weight loss in obese patients in new trial Niveditha Subramani28 Jun 2023 3:00 PM ISTObesity is no longer about looks and cosmetic concern. It's a leading medical problem that increases the risk of other diseases and health...
Investigational FGF21 analogue improves fibrosis in NASH patients: Phase 2b trial Medha Baranwal27 Jun 2023 11:00 AM ISTUSA: Treatment with an investigational FGF21 analogue, pegozafermin, improved fibrosis in patients with NASH (nonalcoholic steatohepatitis), according...
High dose hemodiafiltration may reduce mortality in kidney transplant cases: NEJM Jacinthlyn Sylvia18 Jun 2023 8:00 PM ISTA new study published in The New England Journal of Medicine suggests that high-dose hemodiafiltration reduced the risk of mortality from any cause in...
Early Administration Of DOACs After Ischaemic Stroke Safe and effective in AF patients Dr. Kamal Kant Kohli16 Jun 2023 9:30 AM ISTA recent study published in The New England Journal Of Medicine, known as the ELAN trial, has revealed that starting anticoagulation treatment soon...
Transcatheter repair for tricuspid regurgitation improves quality of life Jacinthlyn Sylvia13 Jun 2023 9:30 AM ISTA new study published in The New England Journal of Medicine suggests that tricuspid transcatheter edge-to-edge repair (TEER) improved quality of...
